Chart of the Day: Bristol-Myers Squibb (BMY)

by Christian Tharp, CMT

Bristol-Myers Squibb (BMY) is trading sideways, within a range, and a rectangle pattern has formed that could lead to a breakout or breakdown sometime soon…


Bristol-Myers Squibb (BMY) discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. The company’s immuno-oncology drug, Opdivo, and its blood thinner, Eliquis, drive growth for the company’s profits. The label expansion of Opdivo should continue to boost revenue.

Take a look at the 1-year chart of Bristol BMY below with added notations…

Continue reading at

(Want free training resources? Check our our training section for videos and tips!)


Good luck!

Christian Tharp, CMT 

Our Experts Found 9 Stocks You Will Hold Forever

With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas for the year ahead. One of the companies highlighted in this report controls the smartphone market and now has its sights set on owning a bigger technology. It has the potential to be the most valuable stock in the history of investing. You need to find out the name of this company before the rest of the market does. This Report Is Completely Free, Download Your Copy Today

Interested in events that actually move the market?Awesome!

Let us send you a recap of every weeks market movers!

Better yet…Receive ALERTS
of Market Moving Events…
seconds after they surface!

  • Mergers & Acquisitions
  • Clinical Trials
  • Contract Awards
  • Stock Repurchase Programs
  • Earnings Announcement

Get Started